Revive (RVVTF) Hits a Snag?
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
First our summary."FDA provided communication that...
IoT Project of the Year? Direct Communications (DCSX)
DCS Nominated for IoT Project of the Year with Smart ESG Program Enabling Companies to Meet Regulatory Requirements and Increases Operation...
Revive Therapeutics (RVVTF) Annual Shareholder Meeting.
ANNUAL SHAREHOLDER MEETING
https://vimeo.com/752050831
Corporate Presentation: Internet of Things Innovator, Direct Communication (DCSX).
CORPORATE PRESENTATION | 8-2022
#DCSX
Adding Iconic Brands (ICNB) $0.20 to Watch List.
Added Iconic to the Beverage Stock Review Watchlist, "Top Beverage Stocks for 2022 and Beyond."
13 Keys to a Successful FDA Advisory Committee Meeting (Regulatory Focus)
RAPS' Latest | 01 August 2019 | By Zachary Brousseau
When the US Food and Drug Administration (FDA) has significant...
DCS (DCSX) Announces Closing of Fully Subscribed USD $1.5 Million Private Placement Financing.
San Diego, California--(Newsfile Corp. - September 9, 2022) - Direct Communication Solutions, Inc. (OTCQX: DCSX) (CSE: DCSI) (FSE: 7QU), a leading provider of...
Adding Progressive Care (RXMD) $0.04 to Watch List.
Adding to Biotech Stock Review 2022 Watch List.
Speculative, Yes. But Pay Down of $2 Million Toxic Note and...
CB Scientific, Inc. (CBSC) Announces FDA 510(k) Submission.
CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor
Updated product to include significant...
Provention Bio (PRVB) Announces $125 Million Term Loan Facility with Hercules Capital
Don't think we've ever seen anything like this before. Most investors who prefer to invest post FDA approval, invest post FDA approval....
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
